|
TUBB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.212000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.654400E-01 |
| Normal-vs-Stage2 |
8.923400E-01 |
| Normal-vs-Stage3 |
7.388000E-01 |
| Normal-vs-Stage4 |
3.410400E-01 |
| Stage1-vs-Stage2 |
6.052200E-01 |
| Stage1-vs-Stage3 |
6.641000E-01 |
| Stage1-vs-Stage4 |
7.862200E-01 |
| Stage2-vs-Stage3 |
9.030800E-01 |
| Stage2-vs-Stage4 |
5.540600E-01 |
| Stage3-vs-Stage4 |
5.576200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.018200E-01 |
| Normal-vs-AfricanAmerican |
5.403200E-01 |
| Normal-vs-Asian |
4.782200E-01 |
| Caucasian-vs-AfricanAmerican |
5.586600E-01 |
| Caucasian-vs-Asian |
3.250600E-01 |
| AfricanAmerican-vs-Asian |
2.835800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.518000E-01 |
| Normal-vs-Female |
3.223000E-01 |
| Male-vs-Female |
4.070200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.501400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.387600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.253800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.239400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.367200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.545800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.985700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.024800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.070400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.656160E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.127200E-01 |
| Classical-VS-Follicular |
1.66923999999069E-05 |
| Classical-VS-Other |
3.017600E-01 |
| Classical-VS-Normal |
6.793000E-01 |
| Tall-VS-Follicular |
5.980100E-03 |
| Tall-VS-Other |
3.622000E-01 |
| Tall-VS-Normal |
6.176400E-01 |
| Follicular-VS-Other |
5.820200E-01 |
| Follicular-VS-Normal |
9.759900E-04 |
| Other-VS-Normal |
3.336400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.690000E-01 |
| Normal-vs-N1 |
8.727800E-02 |
| N0-vs-N1 |
3.660800E-01 |
|
|
